2-Methyl-2-o-tolyloxymethyl-propan | 1991-49-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-Methyl-2-o-tolyloxymethyl-propan
• 英文别名: 1-(2,2-Dimethylpropoxy)-2-methylbenzene
• CAS: 1991-49-7
• 化学式: C₁₂H₁₈O
• 分子量: 178.274
• InChiKey: LJVOWEMFTURFHP-UHFFFAOYSA-N

物化性质

• 沸点：
  96-97 °C(Press: 12 Torr)
• 密度：
  0.910±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-Methyl-2-o-tolyloxymethyl-1,3-bis-tosyloxy-propan 在 lithium aluminium tetrahydride 作用下， 生成 2-Methyl-2-o-tolyloxymethyl-propan
  参考文献：
  名称：

  Seyden-Penne,J. et al., Bulletin de la Societe Chimique de France, 1965, p. 700 - 704

  摘要：

  DOI：

文献信息

• Use of Sonication for the Coupling of Sterically Hindered Substrates in the Phenolic Mitsunobu Reaction
  作者：Salvatore D. Lepore、Yuanjun He

  DOI：10.1021/jo0345751

  日期：2003.10.1

  A vast rate increase in the Mitsunobu reaction of phenols with alcohols where either or both are sterically hindered has been achieved by the use of high concentration combined with sonication.

  通过将高浓度与超声处理结合使用，可以实现酚与醇的Mitsunobu反应的大量增加，其中，任一种或两种都受空间阻碍。
• CRTH2 Receptor Ligands For Therapeutic Use
  申请人：Ulven Trond

  公开号：US20090105218A1

  公开（公告）日：2009-04-23

  Compounds of formula (I) are useful in the treatment of disease responsive to modulation of CRTH2 receptor activity, wherein: A represents a carboxyl group —COOH, or a carboxyl bioisostere; L1 is a bond, —CH 2 —, —OCH 2 —, —CH 2 CH 2 — or —CH═CH—; L2 is CONH—, —NHCO—, SO 2 NR 1 —, —NR 1 SO 2 wherein R 1 is hydrogen or C 1 -C 3 alkyl, or a divalent radical of formula (X) or (Y), wherein ring Q is a non aromatic heterocyclic ring containing 5 to 7 ring atoms, including the nitrogen shown; L3 is a divalent linker radical of formula -(Alk 1 ) m -(Z) n -(Alk 2 ) p as defined in the description; ring Ar 1 is an optionally substituted divalent phenyl radical or divalent 5- or 6-membered monocyclic heteroaryl radical, in which L1 and the H[B] s L3L2Ar 2 CONH-radical are linked to adjacent ring carbon atoms; ring Ar 2 is an optionally substituted 1,3-phenylene radical, or an optionally substituted divalent 5- or 6-membered monocyclic heteroaryl radical, in which AL1Ar 1 NHCO-radical and the H[B] s L3L2-radical are linked to ring carbon atoms which are not in ortho relationship; ring B is as defined for Ar 2 , or an optionally substituted cycloalkyl, N-pyrrolidinyl, N-piperidinyl or N-azepinyl ring; and s is 0 or 1.

  公式（I）的化合物在治疗对CRTH2受体活性调节敏感的疾病中有用，其中：A代表羧基- COOH或羧基生物同位素; L1是键，-CH2-，-O -，- -或-CH═CH-; L2是CONH-，-NHCO-，SO2NR1-，-NR1SO2其中R1是氢或C1-C3烷基，或式（X）或（Y）的双价基团，其中环Q是含有5至7个环原子的非芳香杂环环，包括所示的氮; L3是式-(Alk1)m-(Z)n-(Alk2)pas所定义的双价连接基团; 环Ar1是可选的取代的双价苯基团或双价的5-或6-成员的单环杂芳基团，其中L1和H[B]sL3L2Ar2CONH基团连接到相邻的环碳原子; 环Ar2是可选的取代的1,3-苯基基团，或可选的取代的双价5-或6-成员的单环杂芳基团，在其中AL1Ar1NHCO基团和H[B]sL3L2基团连接到不处于邻位关系的环碳原子; 环B如Ar2所定义，或可选的取代的环烷基，N-吡咯烷基，N-哌啶基或N-氮杂庚基; s为0或1。
• INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS
  申请人：Basu Arnab

  公开号：US20120189614A1

  公开（公告）日：2012-07-26

  Organic compounds showing the ability to inhibit viral glycoprotein (GP)-mediated entry of a filovirus into a host cell are disclosed. The disclosed filovirus entry inhibitor compounds are useful for treating, preventing, or reducing the spread of infections by filovirus including the type species Marburg virus (MARV) and Ebola virus (EBOV). Preferred inhibitors of the invention provide therapeutic agents for combating the Ivory Coast, Sudan, Zaire, Bundibugyo, and Reston Ebola virus strains.

  本发明揭示了有机化合物，表现出抑制病毒糖蛋白（GP）介导的菲罗病毒进入宿主细胞的能力。所揭示的菲罗病毒进入抑制剂化合物可用于治疗、预防或减少菲罗病毒感染的传播，包括类型种马尔堡病毒（MARV）和埃博拉病毒（EBOV）。本发明的优选抑制剂为治疗象牙海岸、苏丹、扎伊尔、邦迪布吉奥和雷斯顿埃博拉病毒株提供治疗剂。
• TREATMENT OF METABOLIC SYNDROME WITH NOVEL AMIDES
  申请人：Hauske James R.

  公开号：US20100292289A1

  公开（公告）日：2010-11-18

  The present invention relates to the treatment of metabolic syndrome or disorders associated with metabolic syndrome comprising administering a compound of the invention.

  本发明涉及治疗代谢综合征或与代谢综合征相关的疾病，包括给予本发明的化合物。
• SYNTHESIS OF ARYL ETHERS, METHODS AND REAGENTS RELATED THERETO
  申请人：MASSACHUSETTS INSTITUTE OF TECHNOLOGY

  公开号：EP1027316A1

  公开（公告）日：2000-08-16